TRISHULA THERAPEUTICS

trishula-therapeutics-logo

Trishula is a privately held company dedicated to the development of TTX-030, a first-in-class, anti-CD39 antibody, in collaboration with AbbVie. TTX-030 inhibits the activity of CD39, an enzyme that converts ATP to AMP, the initial step in the generation of adenosine in the tumor microenvironment. TTX-030 prevents the formation of immune-suppressive extracellular adenosine and maintains high levels of immune-activating extracellular ATP, stimulating dendritic and myeloid-derived cells necessary for both innate and adaptive immunity. Currently, TTX-030 is being studied in phase 1/1b clinical trials as a monotherapy and in combination with an anti-PD-1 agent and standard chemotherapy in adults with advanced cancer (NCT03884556 and NCT04306900).

#SimilarOrganizations #People #Financial #Website #More

TRISHULA THERAPEUTICS

Social Links:

Industry:
Biotechnology Life Science Medical

Founded:
2020-01-01

Address:
South San Francisco, California, United States

Country:
United States

Website Url:
http://www.trishulatx.com

Total Employee:
1+

Status:
Active

Contact:
650-509-5732

Email Addresses:
[email protected]

Total Funding:
0

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Universal Analytics Apache Microsoft Exchange Online Office 365 Mail


Similar Organizations

biobohemia-logo

Biobohemia

Biotechnology company focused on development of cancer vaccines.

innovative-biotherapies-logo

Innovative BioTherapies

Innovative BioTherapies is a biotechnology company that develops medical devices to solve unmet medical needs.

lytica-therapeutics-logo

Lytica Therapeutics

Lytica Therapeutics, Inc. is a biotechnology company focused on developing novel peptide therapeutics.


Current Advisors List

kurt-von-emster_image

Kurt von Emster Board Member @ Trishula Therapeutics
Board_member
2020-10-01

Current Employees Featured

anil-singhal_image

Anil Singhal
Anil Singhal President & CEO @ Trishula Therapeutics
President & CEO
2021-01-01

Founder


anil-singhal_image

Anil Singhal

Investors List

astellas-venture-management_image

Astellas Venture Management

Astellas Venture Management investment in Funding Round - Trishula Therapeutics

mpm-capital_image

MPM Capital

MPM Capital investment in Funding Round - Trishula Therapeutics

Official Site Inspections

http://www.trishulatx.com Semrush global rank: 4.33 M Semrush visits lastest month: 2.64 K

  • Host name: ec2-54-176-110-96.us-west-1.compute.amazonaws.com
  • IP address: 54.176.110.96
  • Location: San Jose United States
  • Latitude: 37.3388
  • Longitude: -121.8914
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 95141

Loading ...

More informations about "Trishula Therapeutics" on Search Engine